{
    "abstract": "Antibody-inducing vaccines are a major focus in the preventive HIV vaccine field. Because the most common tests for HIV infection rely on detecting antibodies to HIV, they may also detect antibodies induced by a candidate HIV vaccine. The detection of vaccine-induced antibodies to HIV by serological tests is most commonly referred to as vaccine-induced sero-reactivity (VISR). VISR can be misinterpreted as a sign of HIV infection in a healthy study participant. In a participant who has developed vaccine-induced antibodies, accurate diagnosis of HIV infection (or lack thereof) may require specialized tests and algorithms (differential testing) that are usually not available in community settings. Organizations sponsoring clinical testing of preventive HIV vaccine candidates have an ethical obligation not only to inform healthy volunteers about the potential problems associated with participating in a clinical trial but also to help manage any resulting issues. This article explores the scope of VISR-related issues that become increasingly prevalent as the search for an effective HIV vaccine continues and will be paramount once a preventive vaccine is deployed. We also describe ways in which organizations conducting HIV vaccine trials have addressed these issues and outline areas where more work is needed.",
    "bib_entries": {
        "bib0005": {
            "authors": [
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "Ackerman"
                },
                {
                    "first": "Galit",
                    "initial": "G.",
                    "last": "Alter"
                }
            ],
            "doi": "10.1056/NEJMcibr1304437",
            "firstpage": "389",
            "issn": "00284793",
            "lastpage": "391",
            "pub_year": 2013,
            "title": "Mapping the journey to an HIV vaccine",
            "volume": "369"
        },
        "bib0010": {
            "authors": [
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                }
            ],
            "doi": "10.1111/imr.12075",
            "firstpage": "225",
            "issn": "01052896",
            "lastpage": "244",
            "pmid": "23772623",
            "pub_year": 2013,
            "title": "HIV-1 Neutralizing Antibodies: Understanding Nature's Pathways",
            "volume": "254"
        },
        "bib0015": {
            "authors": [
                {
                    "first": "Jean Louis",
                    "initial": "J.L.",
                    "last": "Excler"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.4161/hv.28462",
            "firstpage": "1734",
            "issn": "21645515",
            "lastpage": "1746",
            "pmid": "24637946",
            "pub_year": 2014,
            "title": "HIV-1 vaccines: Challenges and new perspectives",
            "volume": "10"
        },
        "bib0020": {
            "authors": [
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "M. Juliana",
                    "initial": "M.J.",
                    "last": "McElrath"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "S. Munir",
                    "initial": "S.M.",
                    "last": "Alam"
                },
                {
                    "first": "David T.",
                    "initial": "D.T.",
                    "last": "Evans"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Chitraporn",
                    "initial": "C.",
                    "last": "Karnasuta"
                },
                {
                    "first": "Ruengpueng",
                    "initial": "R.",
                    "last": "Sutthent"
                },
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "DeVico"
                },
                {
                    "first": "George K.",
                    "initial": "G.K.",
                    "last": "Lewis"
                },
                {
                    "first": "Constance",
                    "initial": "C.",
                    "last": "Williams"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Pinter"
                },
                {
                    "first": "Youyi",
                    "initial": "Y.",
                    "last": "Fong"
                },
                {
                    "first": "Holly",
                    "initial": "H.",
                    "last": "Janes"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "DeCamp"
                },
                {
                    "first": "Yunda",
                    "initial": "Y.",
                    "last": "Huang"
                },
                {
                    "first": "Mangala",
                    "initial": "M.",
                    "last": "Rao"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Billings"
                },
                {
                    "first": "Nicos",
                    "initial": "N.",
                    "last": "Karasavvas"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Viseth",
                    "initial": "V.",
                    "last": "Ngauy"
                },
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "De Souza"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Paris"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Ferrari"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Bailer"
                },
                {
                    "first": "Kelly A.",
                    "initial": "K.A.",
                    "last": "Soderberg"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "Phillip W.",
                    "initial": "P.W.",
                    "last": "Berman"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Frahm"
                },
                {
                    "first": "Stephen C.",
                    "initial": "S.C.",
                    "last": "De Rosa"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Alpert"
                },
                {
                    "first": "Nicole L.",
                    "initial": "N.L.",
                    "last": "Yates"
                },
                {
                    "first": "Xiaoying",
                    "initial": "X.",
                    "last": "Shen"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1056/NEJMoa1113425",
            "firstpage": "1275",
            "issn": "00284793",
            "lastpage": "1286",
            "pub_year": 2012,
            "title": "Immune-correlates analysis of an HIV-1 vaccine efficacy trial",
            "volume": "366"
        },
        "bib0025": {
            "authors": [
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "DeCamp"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "Constance",
                    "initial": "C.",
                    "last": "Williams"
                },
                {
                    "first": "Nicole L.",
                    "initial": "N.L.",
                    "last": "Yates"
                },
                {
                    "first": "William T.",
                    "initial": "W.T.",
                    "last": "Williams"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Howington"
                },
                {
                    "first": "Youyi",
                    "initial": "Y.",
                    "last": "Fong"
                },
                {
                    "first": "Daryl E.",
                    "initial": "D.E.",
                    "last": "Morris"
                },
                {
                    "first": "Kelly A.",
                    "initial": "K.A.",
                    "last": "Soderberg"
                },
                {
                    "first": "Carmela",
                    "initial": "C.",
                    "last": "Irene"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Reichman"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Pinter"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Parks"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "O'Connell"
                },
                {
                    "first": "Zhi Yong",
                    "initial": "Z.Y.",
                    "last": "Yang"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                }
            ],
            "doi": "10.1371/journal.pone.0087572",
            "issn": "19326203",
            "pmid": "24504509",
            "pub_year": 2014,
            "title": "Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection",
            "volume": "9"
        },
        "bib0030": null,
        "bib0035": null,
        "bib0040": null,
        "bib0045": {
            "authors": [
                {
                    "first": "Surender",
                    "initial": "S.",
                    "last": "Khurana"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Needham"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Park"
                },
                {
                    "first": "Bonnie",
                    "initial": "B.",
                    "last": "Mathieson"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Busch"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Nemo"
                },
                {
                    "first": "Phillipe",
                    "initial": "P.",
                    "last": "Nyambi"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Suman",
                    "initial": "S.",
                    "last": "Laal"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Mulenga"
                },
                {
                    "first": "Elwyn",
                    "initial": "E.",
                    "last": "Chomba"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Hunter"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Allen"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "McIntyre"
                },
                {
                    "first": "Indira",
                    "initial": "I.",
                    "last": "Hewlett"
                },
                {
                    "first": "Sherwin",
                    "initial": "S.",
                    "last": "Lee"
                },
                {
                    "first": "Shixing",
                    "initial": "S.",
                    "last": "Tang"
                },
                {
                    "first": "Elliot",
                    "initial": "E.",
                    "last": "Cowan"
                },
                {
                    "first": "Chris",
                    "initial": "C.",
                    "last": "Beyrer"
                },
                {
                    "first": "Marcus",
                    "initial": "M.",
                    "last": "Altfeld"
                },
                {
                    "first": "Xu G.",
                    "initial": "X.G.",
                    "last": "Yu"
                },
                {
                    "first": "Anatole",
                    "initial": "A.",
                    "last": "Tounkara"
                },
                {
                    "first": "Ousmane",
                    "initial": "O.",
                    "last": "Koita"
                },
                {
                    "first": "Anatoli",
                    "initial": "A.",
                    "last": "Kamali"
                },
                {
                    "first": "Nga",
                    "initial": "N.",
                    "last": "Nguyen"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Todd"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Mugenyi"
                },
                {
                    "first": "Omu",
                    "initial": "O.",
                    "last": "Anzala"
                },
                {
                    "first": "Eduard",
                    "initial": "E.",
                    "last": "Sanders"
                },
                {
                    "first": "Nzeera",
                    "initial": "N.",
                    "last": "Ketter"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Fast"
                },
                {
                    "first": "Hana",
                    "initial": "H.",
                    "last": "Golding"
                }
            ],
            "doi": "10.1097/01.qai.0000242465.50947.5f",
            "firstpage": "304",
            "issn": "15254135",
            "lastpage": "312",
            "pmid": "17019363",
            "pub_year": 2006,
            "title": "Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: Utility for detection of diverse HIV-1 subtypes",
            "volume": "43"
        },
        "bib0050": {
            "authors": [
                {
                    "first": "Surender",
                    "initial": "S.",
                    "last": "Khurana"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Needham"
                },
                {
                    "first": "Bonnie",
                    "initial": "B.",
                    "last": "Mathieson"
                },
                {
                    "first": "Isaac R.",
                    "initial": "I.R.",
                    "last": "Rodriguez-Chavez"
                },
                {
                    "first": "Andrew T.",
                    "initial": "A.T.",
                    "last": "Catanzaro"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Bailer"
                },
                {
                    "first": "Jerome",
                    "initial": "J.",
                    "last": "Kim"
                },
                {
                    "first": "Vicky",
                    "initial": "V.",
                    "last": "Polonis"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Cooper"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Guerin"
                },
                {
                    "first": "Michael L.",
                    "initial": "M.L.",
                    "last": "Peterson"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Gurwith"
                },
                {
                    "first": "Nga",
                    "initial": "N.",
                    "last": "Nguyen"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                },
                {
                    "first": "Hana",
                    "initial": "H.",
                    "last": "Golding"
                }
            ],
            "doi": "10.1128/JVI.80.5.2092-2099.2006",
            "firstpage": "2092",
            "issn": "0022538X",
            "lastpage": "2099",
            "pmid": "16474117",
            "pub_year": 2006,
            "title": "Human immunodeficiency virus (HIV) vaccine trials: A novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies",
            "volume": "80"
        },
        "bib0055": {
            "authors": [
                {
                    "first": "Oksana",
                    "initial": "O.",
                    "last": "Penezina"
                },
                {
                    "first": "Neil X.",
                    "initial": "N.X.",
                    "last": "Krueger"
                },
                {
                    "first": "Isaac R.",
                    "initial": "I.R.",
                    "last": "Rodriguez-Chavez"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Busch"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Hural"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "O'Connell"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Hunter"
                },
                {
                    "first": "Said",
                    "initial": "S.",
                    "last": "Aboud"
                },
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Higgins"
                },
                {
                    "first": "Victor",
                    "initial": "V.",
                    "last": "Kovalenko"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Clapham"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Crane"
                },
                {
                    "first": "Andrew E.",
                    "initial": "A.E.",
                    "last": "Levin"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Kilembe"
                },
                {
                    "first": "Etienne",
                    "initial": "E.",
                    "last": "Karita"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Allen"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Munseri"
                },
                {
                    "first": "Agricola",
                    "initial": "A.",
                    "last": "Joachim"
                },
                {
                    "first": "Muhammad",
                    "initial": "M.",
                    "last": "Bakari"
                },
                {
                    "first": "Fred",
                    "initial": "F.",
                    "last": "Mhalu"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Aris"
                },
                {
                    "first": "Charlotta",
                    "initial": "C.",
                    "last": "Nilsson"
                },
                {
                    "first": "Gunnel",
                    "initial": "G.",
                    "last": "Biberfeld"
                },
                {
                    "first": "Merlin",
                    "initial": "M.",
                    "last": "Robb"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Marovich"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Sandstrom"
                }
            ],
            "doi": "10.1128/CVI.00748-13",
            "firstpage": "391",
            "issn": "15566811",
            "lastpage": "398",
            "pmid": "24403525",
            "pub_year": 2014,
            "title": "Performance of a redesigned HIV selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants",
            "volume": "21"
        },
        "bib0060": {
            "authors": [
                {
                    "first": "Surender",
                    "initial": "S.",
                    "last": "Khurana"
                },
                {
                    "first": "Philip J.",
                    "initial": "P.J.",
                    "last": "Norris"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Busch"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Park"
                },
                {
                    "first": "Pretty",
                    "initial": "P.",
                    "last": "Sasono"
                },
                {
                    "first": "Koleka",
                    "initial": "K.",
                    "last": "Mlisana"
                },
                {
                    "first": "Abdool Karim",
                    "initial": "A.K.",
                    "last": "Salim"
                },
                {
                    "first": "Frederick M.",
                    "initial": "F.M.",
                    "last": "Hecht"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Mulenga"
                },
                {
                    "first": "Elwyn",
                    "initial": "E.",
                    "last": "Chomba"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Hunter"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Allen"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Nemo"
                },
                {
                    "first": "Isaac R.",
                    "initial": "I.R.",
                    "last": "Rodriguez-Chavez"
                },
                {
                    "first": "Joseph B.",
                    "initial": "J.B.",
                    "last": "Margolick"
                },
                {
                    "first": "Hana",
                    "initial": "H.",
                    "last": "Golding"
                }
            ],
            "doi": "10.1128/JCM.01573-09",
            "firstpage": "281",
            "issn": "00951137",
            "lastpage": "285",
            "pmid": "19906903",
            "pub_year": 2010,
            "title": "HIV-Selectest enzyme immunoassay and rapid test: Ability to detect seroconversion following HIV-1 infection",
            "volume": "48"
        },
        "bib0065": null,
        "bib0070": {
            "authors": [
                {
                    "first": "Bernard M.",
                    "initial": "B.M.",
                    "last": "Branson"
                },
                {
                    "first": "H. Hunter",
                    "initial": "H.H.",
                    "last": "Handsfield"
                },
                {
                    "first": "Margaret A.",
                    "initial": "M.A.",
                    "last": "Lampe"
                },
                {
                    "first": "Robert S.",
                    "initial": "R.S.",
                    "last": "Janssen"
                },
                {
                    "first": "Allan W.",
                    "initial": "A.W.",
                    "last": "Taylor"
                },
                {
                    "first": "Sheryl B.",
                    "initial": "S.B.",
                    "last": "Lyss"
                },
                {
                    "first": "Jill E.",
                    "initial": "J.E.",
                    "last": "Clark"
                }
            ],
            "firstpage": "1",
            "issn": "15458601",
            "lastpage": "CE1",
            "pmid": "16988643",
            "pub_year": 2006,
            "title": "Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.",
            "volume": "55"
        },
        "bib0075": null,
        "bib0080": {
            "authors": [
                {
                    "first": "Marta Louise",
                    "initial": "M.L.",
                    "last": "Ackers"
                },
                {
                    "first": "Bharat",
                    "initial": "B.",
                    "last": "Parekh"
                },
                {
                    "first": "Thomas G.",
                    "initial": "T.G.",
                    "last": "Evans"
                },
                {
                    "first": "Phillip",
                    "initial": "P.",
                    "last": "Berman"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Phillips"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Allen"
                },
                {
                    "first": "J. Steven",
                    "initial": "J.S.",
                    "last": "McDougal"
                }
            ],
            "doi": "10.1086/368169",
            "firstpage": "879",
            "issn": "00221899",
            "lastpage": "886",
            "pmid": "12660933",
            "pub_year": 2003,
            "title": "Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients",
            "volume": "187"
        },
        "bib0085": {
            "authors": [
                {
                    "first": "Cristine J.",
                    "initial": "C.J.",
                    "last": "Cooper"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Metch"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Dragavon"
                },
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Coombs"
                },
                {
                    "first": "Lindsey R.",
                    "initial": "L.R.",
                    "last": "Baden"
                }
            ],
            "doi": "10.1001/jama.2010.926",
            "firstpage": "275",
            "issn": "00987484",
            "lastpage": "283",
            "pmid": "20639561",
            "pub_year": 2010,
            "title": "Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients",
            "volume": "304"
        },
        "bib0090": {
            "authors": [
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Schmidt"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Jaoko"
                },
                {
                    "first": "Gloria",
                    "initial": "G.",
                    "last": "Omosa-Manyonyi"
                },
                {
                    "first": "Pontiano",
                    "initial": "P.",
                    "last": "Kaleebu"
                },
                {
                    "first": "Juliet",
                    "initial": "J.",
                    "last": "Mpendo"
                },
                {
                    "first": "Annet",
                    "initial": "A.",
                    "last": "Nanvubya"
                },
                {
                    "first": "Etienne",
                    "initial": "E.",
                    "last": "Karita"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Bayingana"
                },
                {
                    "first": "Linda Gail",
                    "initial": "L.G.",
                    "last": "Bekker"
                },
                {
                    "first": "Elwyn",
                    "initial": "E.",
                    "last": "Chomba"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Kilembe"
                },
                {
                    "first": "Maphoshane",
                    "initial": "M.",
                    "last": "Nchabeleng"
                },
                {
                    "first": "Julien",
                    "initial": "J.",
                    "last": "Nyombayire"
                },
                {
                    "first": "Gwynn",
                    "initial": "G.",
                    "last": "Stevens"
                },
                {
                    "first": "Paramesh",
                    "initial": "P.",
                    "last": "Chetty"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Lehrman"
                },
                {
                    "first": "Josephine",
                    "initial": "J.",
                    "last": "Cox"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Allen"
                },
                {
                    "first": "Len",
                    "initial": "L.",
                    "last": "Dally"
                },
                {
                    "first": "Carol",
                    "initial": "C.",
                    "last": "Smith"
                },
                {
                    "first": "Patricia E.",
                    "initial": "P.E.",
                    "last": "Fast"
                }
            ],
            "doi": "10.4161/hv.27559",
            "firstpage": "714",
            "issn": "21645515",
            "lastpage": "723",
            "pmid": "24374365",
            "pub_year": 2014,
            "title": "Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa",
            "volume": "10"
        },
        "bib0095": {
            "authors": [
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Desaint"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Durier"
                },
                {
                    "first": "Armel",
                    "initial": "A.",
                    "last": "Poda"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Krivine"
                },
                {
                    "first": "Fran\u00e7ois",
                    "initial": "F.",
                    "last": "Simon"
                },
                {
                    "first": "H\u00e9l\u00e8ne",
                    "initial": "H.",
                    "last": "Bodilis"
                },
                {
                    "first": "Gilles",
                    "initial": "G.",
                    "last": "Pialoux"
                },
                {
                    "first": "Lise",
                    "initial": "L.",
                    "last": "Cuzin"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Poizot-Martin"
                },
                {
                    "first": "Pascale",
                    "initial": "P.",
                    "last": "Morineau"
                },
                {
                    "first": "Jean Daniel",
                    "initial": "J.D.",
                    "last": "Leli\u00e8vre"
                },
                {
                    "first": "Benjamin",
                    "initial": "B.",
                    "last": "Silbermann"
                },
                {
                    "first": "Jean Pierre",
                    "initial": "J.P.",
                    "last": "Aboulker"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Launay"
                }
            ],
            "doi": "10.4172/2155-6113.1000275",
            "issn": "21556113",
            "pub_year": 2014,
            "title": "Long-term persistence of vaccine-induced HIV seropositivity in healthy volunteers",
            "volume": "5"
        },
        "bib0100": {
            "authors": [
                {
                    "first": "Benjamin",
                    "initial": "B.",
                    "last": "Silbermann"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Tod"
                },
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Desaint"
                },
                {
                    "first": "Gilles",
                    "initial": "G.",
                    "last": "Pialoux"
                },
                {
                    "first": "Karine",
                    "initial": "K.",
                    "last": "Petitprez"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Slama"
                },
                {
                    "first": "Hubert",
                    "initial": "H.",
                    "last": "Poncelet"
                },
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Moreau"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Mazarin"
                },
                {
                    "first": "Farad",
                    "initial": "F.",
                    "last": "Heshmati"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Salmon-Ceron"
                },
                {
                    "first": "Jean Gerard",
                    "initial": "J.G.",
                    "last": "Guillet"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Launay"
                }
            ],
            "doi": "10.1089/aid.2008.0107",
            "firstpage": "1445",
            "issn": "08892229",
            "lastpage": "1448",
            "pmid": "19000023",
            "pub_year": 2008,
            "title": "Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteers",
            "volume": "24"
        },
        "bib0105": null,
        "bib0110": null
    },
    "body_text": [
        {
            "endOffset": 20669,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The profile of the elicited immune responses and resulting VISR is affected by various characteristics of the HIV vaccine candidates, such as the viral components being targeted and the delivery technologies used.",
            "startOffset": 20456,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 21945,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The confounding effects of VISR on HIV diagnostics are due to the fact that these tests are based on detection of antibodies (Fig. 1).",
            "startOffset": 21811,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 37404,
            "parents": [],
            "secId": "sec0055",
            "sentence": "These recommendations may serve as a field-wide roadmap to a coordinated effort and as a baseline for assessing the state of the field in the future.",
            "startOffset": 37255,
            "title": "Conclusions"
        },
        {
            "endOffset": 27567,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "At the end of the study, participants are tested for HIV infection using study-specific diagnostic algorithms and for VISR using diagnostic serologic kits used in the community.",
            "startOffset": 27390,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 29997,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "refoffsets": {
                "bib0075": {
                    "endOffset": 29801,
                    "startOffset": 29797
                }
            },
            "secId": "sec0030",
            "sentence": "The HVTN has addressed this issue by creating the \u201cVISP Testing Service\u201d [15] with a toll free number for the US (and soon for South Africa) distributed in emails and brochures and posted on the HVTN website to ensure participants have a permanent contact with the sponsor.",
            "startOffset": 29724,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 33696,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "Recommended: the research community to continue to study VISR and publish systematic studies and case reports to enable clinical researchers to better anticipate, prevent, and mitigate the impact of VISR on participants.",
            "startOffset": 33476,
            "title": "Scientific community"
        },
        {
            "endOffset": 34434,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "refoffsets": {
                "bib0075": {
                    "endOffset": 34433,
                    "startOffset": 34429
                }
            },
            "secId": "sec0045",
            "sentence": "As an example, the FHCRC/University of Washington Vaccine CRS, located in Seattle, WA, worked with public health authorities in Washington State to incorporate VISR education into state-mandated healthcare provider training, including the health department's training sessions on HIV testing and counseling [15].",
            "startOffset": 34122,
            "title": "Healthcare providers"
        },
        {
            "endOffset": 23428,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Qualitative nucleic acid (DNA or RNA or both) assays face similar challenges, but may provide a cheaper and more reliable alternative.",
            "startOffset": 23294,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 26370,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0020",
            "sentence": "The participants are informed that VISR may persist for prolonged periods of time, perhaps years, and that the study organization or sponsor will provide long-term support to ensure accurate testing and to address any resulting social harms.",
            "startOffset": 26129,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 23839,
            "parents": [],
            "secId": "sec0010",
            "sentence": "In addition to the challenge of technological feasibility, the tests must be adaptable to low-resource settings where electricity and cold chain are not always available.",
            "startOffset": 23669,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 33414,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "The data on VISR will continue to evolve as new vaccine candidates and HIV tests are developed.",
            "startOffset": 33319,
            "title": "Scientific community"
        },
        {
            "endOffset": 32080,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "However, individuals may decline the card or be uncomfortable carrying such a document.",
            "startOffset": 31993,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 31607,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "Once trial participation is confirmed, trial sponsors can communicate on behalf of the participant and/or issue documentation such as a \u201ccertificate of trial participation\u201d to help the participants demonstrate their need for specialized HIV testing.",
            "startOffset": 31358,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 20831,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In addition, duration of VISR status is also very variable.",
            "startOffset": 20772,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 27163,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0020",
            "sentence": "The availability of over-the-counter in-home tests may further exacerbate these HIV testing challenges.",
            "startOffset": 27060,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 22418,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Several small companies are making good progress toward differential tests.",
            "startOffset": 22343,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 32499,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "While it is impossible to predict the frequency and duration of VISR before a trial, clinical researchers need to be prepared to prevent and mitigate various social harms encountered by participants with VISR.",
            "startOffset": 32290,
            "title": "Scientific community"
        },
        {
            "endOffset": 26128,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0020",
            "sentence": "The participants are told that they should be tested for HIV infection only at clinical research sites (CRS) and strongly advised against community-based testing.",
            "startOffset": 25966,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 29533,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "All clinical trial organizations maintain records with identifiers and study regimens that can verify a person's participation in the vaccine arm of a study.",
            "startOffset": 29376,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 21211,
            "parents": [],
            "secId": "sec0005",
            "sentence": "A study participant who tested sero-negative at the time of study exit may still harbor HIV antibodies that could be detected by different or newly available tests.",
            "startOffset": 21047,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 22774,
            "parents": [],
            "refoffsets": {
                "bib0055": {
                    "endOffset": 22773,
                    "startOffset": 22766
                },
                "bib0060": {
                    "endOffset": 22773,
                    "startOffset": 22766
                }
            },
            "secId": "sec0010",
            "sentence": "HIV-Selectest has been tested against specimens from a number of clinical trials with good results [11,12].",
            "startOffset": 22667,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 21046,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Commercially available tests have different specificity and sensitivity, which may result in different VISR outcomes.",
            "startOffset": 20929,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 30633,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "refoffsets": {
                "bib0075": {
                    "endOffset": 30554,
                    "startOffset": 30550
                }
            },
            "secId": "sec0030",
            "sentence": "The HVTN, for example, created the \u201cVISP Registry\u201d [15] and recently mandated that all trial participants be included in the registry.",
            "startOffset": 30499,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 25145,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The issues associated with VISR have been recognized for years, and organizations conducting clinical HIV vaccine studies are addressing them to various degrees.",
            "startOffset": 24984,
            "title": "Current practices and areas for improvement"
        },
        {
            "endOffset": 31358,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "Recommended: trial sponsors to consider creating a secure participant registry to facilitate access to records, including cross-sponsor regional or national registries.",
            "startOffset": 31190,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 21600,
            "parents": [],
            "secId": "sec0005",
            "sentence": "While developing antibodies to HIV does not result in physiological harm, the evolution of the HIV diagnostic and vaccine research fields have created the potential for negative social impacts for individuals with such vaccine-induced antibodies.",
            "startOffset": 21354,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 29723,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "However, since the records are usually maintained by the trial sites, it may be difficult for participants to gain access to the information if the site closes or the participant relocates.",
            "startOffset": 29534,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 30814,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "The United States Army Medical Research and Materiel Command (USAMRMC) in the US and Thailand also collects data from all trial participants into the \u2018Volunteer Registry Database\u2019.",
            "startOffset": 30634,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 37028,
            "parents": [],
            "secId": "sec0055",
            "sentence": "Trial sponsors recognize an ethical obligation to support trial participants to the best of their abilities, and many sponsors currently spend considerable resources to study and mitigate the potential harms encountered by participants with VISR.",
            "startOffset": 36782,
            "title": "Conclusions"
        },
        {
            "endOffset": 30498,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "To quickly identify former trial participants, some organizations have created dedicated registries in which the name of the participant is readily matched to the study regimen and identifiers.",
            "startOffset": 30305,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 23037,
            "parents": [],
            "secId": "sec0010",
            "sentence": "With regard to detecting viral components, monoclonal antibodies can be used to detect viral proteins, such as capsid protein (p24), in the blood, but tests based on this strategy must overcome the challenge of plasma antibodies competing with the assay antibody.",
            "startOffset": 22774,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 27778,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Commercially available tests are constantly evolving, and new tests may have different specificity or sensitivity for detecting vaccine-induced antibodies.",
            "startOffset": 27623,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 28603,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Only five of the nine surveyed organizations have a system in place for remote testing; other organizations indicated that they provide such support on a case-by-case basis.",
            "startOffset": 28430,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 35666,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0050",
            "sentence": "Recommended: in-country health authorities to ensure that national guidelines for HIV testing identify VISR as a potential confounder for interpreting serological test results.",
            "startOffset": 35490,
            "title": "HIV testing"
        },
        {
            "endOffset": 28429,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "If no other CRS exists near a relocated participant, arrangements have to be made to draw blood and to ship the samples back to the organization or affiliated laboratory for testing.",
            "startOffset": 28247,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 29343,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Recommended: the HIV vaccine field, together with regulatory authorities and public health agencies, to set aside contingency resources to assure that trial records are maintained and all testing needs are met in the future, independent of funding availability for individual programs.",
            "startOffset": 29058,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 24768,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Thus, it is highly unlikely that the challenges that trial participants with VISR face in the community will have simple/rapid technological solutions in the near future.",
            "startOffset": 24598,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 27941,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Alternatively, participants may relocate to a community where different commercial HIV screening tests are used, which could also lead to a change in VISR status.",
            "startOffset": 27779,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 30304,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "Because records are not kept in a centralized location, the time to access records may vary depending on the responsiveness of the trial site.",
            "startOffset": 30162,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 24377,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Therefore the development of differential HIV tests capable of distinguishing VISR from HIV infection entails more regulatory and logistical complexities than other diagnostic areas, discouraging large diagnostic companies from investing in such specialized tests.",
            "startOffset": 24113,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 34016,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0045",
            "sentence": "When HIV testing is performed at the doctor's office, the physician who knows to ask about the patient's past or current participation in a vaccine trial can avoid potential misdiagnosis and unnecessary treatment.",
            "startOffset": 33803,
            "title": "Healthcare providers"
        },
        {
            "endOffset": 28140,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Differential testing after the trial is typically managed through the CRS.",
            "startOffset": 28066,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 26864,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 26863,
                    "startOffset": 26859
                }
            },
            "secId": "sec0020",
            "sentence": "However, according to recommendations for HIV testing by the Centers for Disease Control and Prevention, individuals can be tested for HIV under a general consent for all medical care and that pre-test counseling is not required as part of screening programs in healthcare settings [14].",
            "startOffset": 26577,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 30162,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "Recommended: trial sponsors to provide a permanent point of contact for all trial participants to obtain confirmation of participation in the vaccine arm of a study.",
            "startOffset": 29997,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 31765,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "The certificate is a portable identifier that documents past participation in a vaccine study, but cannot attest to the current HIV status of the individual.",
            "startOffset": 31608,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 36434,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0050",
            "sentence": "Recommended: test manufacturers to include language about the possibility of VISR interference with testing in package inserts for commercially available serological HIV tests worldwide.",
            "startOffset": 36248,
            "title": "HIV testing"
        },
        {
            "endOffset": 22666,
            "parents": [],
            "secId": "sec0010",
            "sentence": "HIV-Selectest detects antibodies to a region in gp41 that is rarely included in vaccine immunogens and can therefore be used for differential serologic testing.",
            "startOffset": 22506,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 36248,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0050",
            "sentence": "The World Health Organization could play a role in helping to ensure that similar advisory language is implemented worldwide, e.g. through its prequalification processes for medicinal products, including diagnostic tests.",
            "startOffset": 36027,
            "title": "HIV testing"
        },
        {
            "endOffset": 24466,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Licensure of an HIV vaccine would drastically increase the need for differential testing.",
            "startOffset": 24377,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 37101,
            "parents": [],
            "secId": "sec0055",
            "sentence": "However, more long-term and universally applicable solutions are needed.",
            "startOffset": 37029,
            "title": "Conclusions"
        },
        {
            "endOffset": 20771,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Small changes in vaccine regimens, such as the dose of a single component, may affect VISR frequency.",
            "startOffset": 20670,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 23943,
            "parents": [],
            "secId": "sec0010",
            "sentence": "These technologies must also be portable, easy to use with little training, and inexpensive to operate.",
            "startOffset": 23840,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 29058,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "As the number of participants in HIV vaccine clinical trials increases, the cost to manage long-term HIV testing for participants is expected to become a major expense for clinical trial programs.",
            "startOffset": 28862,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 25796,
            "parents": [],
            "secId": "sec0015",
            "sentence": "A survey of nine organizations conducting HIV vaccine clinical trials showed that while the most essential of these activities are implemented by many of the organizations, other activities are less widespread or need to be refined (Table 3).",
            "startOffset": 25554,
            "title": "Current practices and areas for improvement"
        },
        {
            "endOffset": 32676,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "refoffsets": {
                "bib0080": {
                    "endOffset": 32675,
                    "startOffset": 32668
                },
                "bib0085": {
                    "endOffset": 32675,
                    "startOffset": 32668
                },
                "bib0090": {
                    "endOffset": 32675,
                    "startOffset": 32668
                },
                "bib0095": {
                    "endOffset": 32675,
                    "startOffset": 32668
                },
                "bib0100": {
                    "endOffset": 32675,
                    "startOffset": 32668
                },
                "bib0105": {
                    "endOffset": 32675,
                    "startOffset": 32668
                }
            },
            "secId": "sec0040",
            "sentence": "Multiple groups have presented at conferences and published peer-reviewed articles on the rate and durability of VISR in trial participants, as well as on social harms [16\u201321].",
            "startOffset": 32500,
            "title": "Scientific community"
        },
        {
            "endOffset": 23293,
            "parents": [],
            "secId": "sec0010",
            "sentence": "However, this assay is complex, expensive, and may give false-negative results in individuals who naturally control viral load or are on ARV medications.",
            "startOffset": 23140,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 22505,
            "parents": [],
            "refoffsets": {
                "bib0045": {
                    "endOffset": 22459,
                    "startOffset": 22453
                },
                "bib0050": {
                    "endOffset": 22459,
                    "startOffset": 22453
                },
                "bib0055": {
                    "endOffset": 22459,
                    "startOffset": 22453
                }
            },
            "secId": "sec0010",
            "sentence": "One such example is HIV-Selectest [9\u201311], which is being developed by Immunetics, Inc.",
            "startOffset": 22419,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 19740,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The detection of vaccine-induced antibodies to HIV by serological tests is most commonly referred to as vaccine-induced sero-reactivity (VISR)2 or vaccine-induced sero-positivity (VISP) (Fig. 1).",
            "startOffset": 18638,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 24112,
            "parents": [],
            "refoffsets": {
                "bib0065": {
                    "endOffset": 24111,
                    "startOffset": 24107
                }
            },
            "secId": "sec0010",
            "sentence": "From a regulatory perspective, the FDA considers HIV tests as Class III devices (i.e., high-risk medical devices), which is the most stringent regulatory category [13].",
            "startOffset": 23944,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 32265,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0035",
            "sentence": "Information about VISR frequency, duration, and impact on life needs to be gathered and disseminated to relevant stakeholders.",
            "startOffset": 32139,
            "title": "Raising awareness about the existence and impact of VISR"
        },
        {
            "endOffset": 37254,
            "parents": [],
            "secId": "sec0055",
            "sentence": "In this article, we aimed to identify the gaps in the current landscape as well as the stakeholders best positioned to take action in each area (Box 1).",
            "startOffset": 37102,
            "title": "Conclusions"
        },
        {
            "endOffset": 24940,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Therefore, it is up to the organizations sponsoring these studies to help study participants avoid social harm by offering support and state-of-the art diagnostic testing.",
            "startOffset": 24769,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 34568,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "refoffsets": {
                "bib0110": {
                    "endOffset": 34502,
                    "startOffset": 34498
                }
            },
            "secId": "sec0045",
            "sentence": "Websites, such as the public section of HVTN's website on VISP [22], can be a useful resource both to physicians and to participants.",
            "startOffset": 34435,
            "title": "Healthcare providers"
        },
        {
            "endOffset": 23669,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The only nucleic acid-based diagnostic test for HIV infection approved by the US Food and Drug Administration (FDA) is the Aptima HIV-1 RNA assay (Hologic), and there are few point-of-care nucleic acid-based diagnostic tests in development.",
            "startOffset": 23429,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 28066,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Therefore, all trial participants, even those without VISR at the end of study, may need differential testing in the future.",
            "startOffset": 27942,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 36026,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0050",
            "sentence": "In the US, the FDA works with manufacturers to include the following language about VISR in package inserts for HIV serological tests: \u201cA person who has antibodies to HIV-1 is presumed to be infected with the virus except that a person who has participated in an HIV vaccine study may develop antibodies to the vaccine and may or may not be infected with HIV.\u201d",
            "startOffset": 35666,
            "title": "HIV testing"
        },
        {
            "endOffset": 20929,
            "parents": [],
            "refoffsets": {
                "bib0030": {
                    "endOffset": 20928,
                    "startOffset": 20925
                }
            },
            "secId": "sec0005",
            "sentence": "In some cases HIV antibody responses have persisted for more than 20 years after vaccination [6].",
            "startOffset": 20832,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 27623,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "This service is provided by all organizations surveyed.",
            "startOffset": 27568,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 28246,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "If participants move away from their original study site, access to long-term testing may be compromised.",
            "startOffset": 28141,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 36547,
            "parents": [],
            "secId": "sec0055",
            "sentence": "VISR may be viewed as a straightforward challenge that can be addressed using available technologies.",
            "startOffset": 36446,
            "title": "Conclusions"
        },
        {
            "endOffset": 26576,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0020",
            "sentence": "At the end of study, participants with VISR status are counseled to contact their CRS before any community-based HIV testing and to inform their regular doctor about their participation in a vaccine study.",
            "startOffset": 26371,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 35050,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0050",
            "sentence": "In 2006, the US CDC published its Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings, which specifically mentions participants in HIV vaccine trials: \u201cRecipients of preventive HIV vaccines might have vaccine-induced antibodies that are detectable by HIV antibody tests.",
            "startOffset": 34725,
            "title": "HIV testing"
        },
        {
            "endOffset": 35348,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 35347,
                    "startOffset": 35343
                }
            },
            "secId": "sec0050",
            "sentence": "Persons whose test results are HIV positive and who are identified as vaccine trial participants might not be infected with HIV and should be encouraged to contact or return to their trial site or an associated trial site for the confirmatory testing necessary to determine their HIV status\u201d [14].",
            "startOffset": 35051,
            "title": "HIV testing"
        },
        {
            "endOffset": 34121,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0045",
            "sentence": "Physicians should also be aware of the availability of differential testing performed by trial sponsors.",
            "startOffset": 34017,
            "title": "Healthcare providers"
        },
        {
            "endOffset": 36781,
            "parents": [],
            "secId": "sec0055",
            "sentence": "However, the unpredictable nature of the phenomenon, its potentially long duration, and the complexity of social interactions associated with HIV testing make the delivery of these technologies expensive and logistically challenging.",
            "startOffset": 36548,
            "title": "Conclusions"
        },
        {
            "endOffset": 33802,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0045",
            "sentence": "Education of healthcare providers could significantly reduce VISR-related issues.",
            "startOffset": 33721,
            "title": "Healthcare providers"
        },
        {
            "endOffset": 22136,
            "parents": [],
            "refoffsets": {
                "bib0035": {
                    "endOffset": 22135,
                    "startOffset": 22130
                },
                "bib0040": {
                    "endOffset": 22135,
                    "startOffset": 22130
                }
            },
            "secId": "sec0010",
            "sentence": "Although the fourth generation of diagnostic HIV tests includes detection of viral antigens, they continue to detect antibodies and, therefore, are unlikely to address VISR challenges [7,8].",
            "startOffset": 21946,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 28861,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Unknowns about the frequency and durability of VISR make it challenging for trial sponsors to plan and budget for long-term testing.",
            "startOffset": 28729,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 24597,
            "parents": [],
            "secId": "sec0010",
            "sentence": "However, in the absence of a widely available HIV vaccine, serological tests are likely to remain the primary diagnostic approach.",
            "startOffset": 24467,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 28729,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0025",
            "sentence": "Recommended: trial sponsors to establish procedures to provide accurate HIV testing to all participants for as long as needed.",
            "startOffset": 28603,
            "title": "Providing accurate testing in the long term"
        },
        {
            "endOffset": 33319,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "While all organizations encourage enrollment in LTFU studies, access to testing is not contingent on participation.",
            "startOffset": 33204,
            "title": "Scientific community"
        },
        {
            "endOffset": 25965,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0020",
            "sentence": "All surveyed organizations provide information to study participants about the existence of VISR at the time of informed consent.",
            "startOffset": 25836,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 21732,
            "parents": [],
            "secId": "sec0005",
            "sentence": "This situation can be addressed on two fronts: changes in diagnostic technologies and measures to prevent or mitigate social harms.",
            "startOffset": 21601,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 32991,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "These studies are IRB approved and can be used for research purposes, including research on the incidence and duration of VISR and the nature of social harms.",
            "startOffset": 32833,
            "title": "Scientific community"
        },
        {
            "endOffset": 33476,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "The data regarding country-specific challenges remain sparse.",
            "startOffset": 33415,
            "title": "Scientific community"
        },
        {
            "endOffset": 20025,
            "parents": [],
            "refoffsets": {
                "bib0005": {
                    "endOffset": 19879,
                    "startOffset": 19874
                },
                "bib0010": {
                    "endOffset": 19879,
                    "startOffset": 19874
                },
                "bib0015": {
                    "endOffset": 19879,
                    "startOffset": 19874
                },
                "bib0020": {
                    "endOffset": 19879,
                    "startOffset": 19874
                },
                "bib0025": {
                    "endOffset": 19879,
                    "startOffset": 19874
                }
            },
            "secId": "sec0005",
            "sentence": "While eliciting broadly-reactive, long-lasting antibody responses to HIV is generally viewed as desirable for HIV vaccine candidates [1\u20135], trial participants that develop antibodies to HIV and, as a result, VISR status, may experience a number of challenges in their day-to-day life.",
            "startOffset": 19741,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 20455,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In clinical studies, the frequency of VISR has varied extensively depending on several factors (Table 2).",
            "startOffset": 20350,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 22342,
            "parents": [],
            "secId": "sec0010",
            "sentence": "One way to prevent the complications of VISR is to develop tests that detect non-vaccine antibody responses or viral components, such as proteins, RNA, or DNA and to promote their use in community settings.",
            "startOffset": 22136,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 23139,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Detection of HIV RNA by quantitative PCR is highly accurate and is used in management of HIV disease.",
            "startOffset": 23038,
            "title": "Technical approaches to differentiate vaccine-induced responses from infection"
        },
        {
            "endOffset": 31992,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "For example, the NIAID Vaccine Research Program offers photo ID cards that indicate participation in a trial (the word \u201cHIV\u201d is not included to reduce the chances of stigmatization) and provide contact information for the CRS.",
            "startOffset": 31766,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 27059,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0020",
            "sentence": "While individuals can \u201copt-out\u201d of HIV testing, the process may be confusing for some, especially if they are not aware of this practice beforehand and/or present at a hospital for an emergency.",
            "startOffset": 26865,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 33203,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "refoffsets": {
                "bib0075": {
                    "endOffset": 33202,
                    "startOffset": 33198
                }
            },
            "secId": "sec0040",
            "sentence": "Participants can be followed either for a set number of years or for an open-ended period, as in the HVTN 910 protocol [15].",
            "startOffset": 33079,
            "title": "Scientific community"
        },
        {
            "endOffset": 31190,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0030",
            "sentence": "While the creation of regional or national study participant registries has been strongly advised by some, it faces a number of challenges: merging data from different trial organizations into a common secure database is technically complex, in-country regulatory authorities and ethics committees need to be consulted, and such registries must comply with local privacy laws.",
            "startOffset": 30814,
            "title": "Confirming trial participation"
        },
        {
            "endOffset": 33078,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "Such trials may help clarify the actual needs of participants with VISR in the future.",
            "startOffset": 32992,
            "title": "Scientific community"
        },
        {
            "endOffset": 34709,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0045",
            "sentence": "Recommended: trial sponsors to inform and educate healthcare providers about VISR in the areas where sponsors are conducting clinical trials.",
            "startOffset": 34568,
            "title": "Healthcare providers"
        },
        {
            "endOffset": 20350,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Social harms associated with VISR have included disruption of personal relationships; difficulties in finding or keeping employment; difficulties in obtaining insurance; impediments to travel; inability to enlist into the military; inability to donate blood, sperm, and organs; and inappropriate medical treatment (Table 1).",
            "startOffset": 20026,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 25553,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The solutions can be divided into four general categories: (a) educate participants of the potential for VISR and how it may impact their lives, (b) provide ongoing differential testing for former vaccine trial participants who have VISR, (c) help manage any social harms that occur as a result of the participant's VISR status, and (d) educate the investigators, community, healthcare providers about VISR.",
            "startOffset": 25146,
            "title": "Current practices and areas for improvement"
        },
        {
            "endOffset": 32832,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0040",
            "sentence": "Five clinical trial organizations offer participants the opportunity to enroll in long-term follow-up (LTFU) observational studies once the trial is closed.",
            "startOffset": 32676,
            "title": "Scientific community"
        },
        {
            "endOffset": 21354,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Therefore a negative VISR status at the end of a study does not guarantee that a participant will not need differential testing in the future.",
            "startOffset": 21212,
            "title": "Scope of the problem"
        },
        {
            "endOffset": 27344,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                }
            ],
            "secId": "sec0020",
            "sentence": "Recommended: trial sponsors to strongly advise all participants to inform their primary care physician about their participation in an HIV vaccine trial and the possibility of VISR.",
            "startOffset": 27163,
            "title": "Educate study participants about VISR"
        },
        {
            "endOffset": 35490,
            "parents": [
                {
                    "id": "sec0015",
                    "title": "Current practices and areas for improvement"
                },
                {
                    "id": "sec0035",
                    "title": "Raising awareness about the existence and impact of VISR"
                }
            ],
            "secId": "sec0050",
            "sentence": "Similar considerations are expected to be included in the updated 2014 guidelines (personal communication to authors from Michele Owen, CDC).",
            "startOffset": 35349,
            "title": "HIV testing"
        }
    ],
    "docId": "S0264410X14014303",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Yegor",
                "initial": "Y.",
                "last": "Voronin"
            },
            {
                "email": null,
                "first": "Helene",
                "initial": "H.",
                "last": "Zinszner"
            },
            {
                "email": null,
                "first": "Carissa",
                "initial": "C.",
                "last": "Karg"
            },
            {
                "email": null,
                "first": "Katie",
                "initial": "K.",
                "last": "Brooks"
            },
            {
                "email": null,
                "first": "Robert",
                "initial": "R.",
                "last": "Coombs"
            },
            {
                "email": null,
                "first": "John",
                "initial": "J.",
                "last": "Hural"
            },
            {
                "email": null,
                "first": "Renee",
                "initial": "R.",
                "last": "Holt"
            },
            {
                "email": null,
                "first": "Pat",
                "initial": "P.",
                "last": "Fast"
            },
            {
                "email": null,
                "first": "Mary",
                "initial": "M.",
                "last": "Allen"
            },
            {
                "email": null,
                "first": "Michael",
                "initial": "M.",
                "last": "Busch"
            },
            {
                "email": null,
                "first": "Ulrich",
                "initial": "U.",
                "last": "Fruth"
            },
            {
                "email": null,
                "first": "Hana",
                "initial": "H.",
                "last": "Golding"
            },
            {
                "email": null,
                "first": "Surender",
                "initial": "S.",
                "last": "Khurana"
            },
            {
                "email": null,
                "first": "Joseph",
                "initial": "J.",
                "last": "Mulenga"
            },
            {
                "email": null,
                "first": "Sheila",
                "initial": "S.",
                "last": "Peel"
            },
            {
                "email": null,
                "first": "Marco",
                "initial": "M.",
                "last": "Schito"
            },
            {
                "email": null,
                "first": "Nomampondo",
                "initial": "N.",
                "last": "Barnabas"
            },
            {
                "email": null,
                "first": "Christopher",
                "initial": "C.",
                "last": "Bentsen"
            },
            {
                "email": null,
                "first": "Barney",
                "initial": "B.",
                "last": "Graham"
            },
            {
                "email": null,
                "first": "Glenda",
                "initial": "G.",
                "last": "Gray"
            },
            {
                "email": null,
                "first": "Andrew",
                "initial": "A.",
                "last": "Levin"
            },
            {
                "email": null,
                "first": "Margaret",
                "initial": "M.",
                "last": "McCluskey"
            },
            {
                "email": null,
                "first": "Robert",
                "initial": "R.",
                "last": "O'Connell"
            },
            {
                "email": null,
                "first": "Bill",
                "initial": "B.",
                "last": "Snow"
            },
            {
                "email": null,
                "first": "Mark",
                "initial": "M.",
                "last": "Ware"
            }
        ],
        "doi": "10.1016/j.vaccine.2014.10.040",
        "firstpage": "1243",
        "issn": "0264410X",
        "keywords": [
            "HIV",
            "VISP",
            "VISR",
            "Vaccine",
            "Vaccine-induced sero-positivity",
            "Vaccine-induced sero-reactivity"
        ],
        "lastpage": "1249",
        "openaccess": "Full",
        "pub_year": 2015,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "HIV vaccine-induced sero-reactivity: A challenge for trial participants, researchers, and physicians"
    }
}